Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society.

PubWeight™: 2.23‹?› | Rank: Top 2%

🔗 View Article (PMID 18464753)

Published in Obesity (Silver Spring) on May 08, 2008

Authors

David B Allison1, Morgan Downey, Richard L Atkinson, Charles J Billington, George A Bray, Robert H Eckel, Eric A Finkelstein, Michael D Jensen, Angelo Tremblay

Author Affiliations

1: Department of Biostatistics and Clinical Nutrition Research Center, University of Alabama at Birmingham, Birmingham, Alabama, USA. Dallison@UAB.edu

Articles citing this

Treatment of obesity in primary care practice in the United States: a systematic review. J Gen Intern Med (2009) 2.89

The medical risks of obesity. Postgrad Med (2009) 2.15

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring) (2011) 2.09

Direct medical cost of overweight and obesity in the USA: a quantitative systematic review. Obes Rev (2011) 1.95

Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci (2011) 1.16

Lifestyle interventions for the treatment of class III obesity: a primary target for nutrition medicine in the obesity epidemic. Am J Clin Nutr (2009) 1.16

Putative environmental-endocrine disruptors and obesity: a review. Curr Opin Endocrinol Diabetes Obes (2008) 1.11

Overweight and obesity among low-income Muslim Uyghur women in far western China: correlations of body mass index with blood lipids and implications in preventive public health. PLoS One (2014) 0.95

The 'obesity paradox': a parsimonious explanation for relations among obesity, mortality rate and aging? Int J Obes (Lond) (2010) 0.91

Networks of trainees: examining the effects of attending an interdisciplinary research training camp on the careers of new obesity scholars. J Multidiscip Healthc (2014) 0.83

Short-term high-fat-and-fructose feeding produces insulin signaling alterations accompanied by neurite and synaptic reduction and astroglial activation in the rat hippocampus. J Cereb Blood Flow Metab (2014) 0.82

Bariatric surgery for obese children and adolescents: a review of the moral challenges. BMC Med Ethics (2013) 0.81

Obesity and non-fatal motor vehicle crash injuries: sex difference effects. Int J Obes (Lond) (2011) 0.81

Healthy lifestyle behaviors and decreased risk of mortality in a large prospective study of U.S. women and men. Eur J Epidemiol (2013) 0.81

Physiological responses to psychological stress: importance of adiposity in men aged 50-70 years. Endocr Connect (2014) 0.80

Does comorbid obesity impact quality of life outcomes in patients undergoing endoscopic sinus surgery? Int Forum Allergy Rhinol (2015) 0.80

The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA. Pharmacoeconomics (2015) 0.79

Why patients seek bariatric surgery: does insurance coverage matter? Obes Surg (2014) 0.78

The extracellular N-terminal domain of G-protein coupled receptor 83 regulates signaling properties and is an intramolecular inverse agonist. BMC Res Notes (2014) 0.77

ADV36 adipogenic adenovirus in human liver disease. World J Gastroenterol (2014) 0.76

Chemical-shift water-fat MRI of white adipose depots: inability to resolve cell size differences. Int J Body Compos Res (2013) 0.76

Weight loss endoscopy: Development, applications, and current status. World J Gastroenterol (2016) 0.75

No compelling evidence that sibutramine prolongs life in rodents despite providing a dose-dependent reduction in body weight. Int J Obes (Lond) (2010) 0.75

The Saudi clinical practice guideline for the management of overweight and obesity in adults. Saudi Med J (2016) 0.75

Regarding Obesity as a Disease: Evolving Policies and Their Implications. Endocrinol Metab Clin North Am (2016) 0.75

The downfalls of BMI-focused policies. Int J Obes (Lond) (2016) 0.75

Fat-water MRI of a diet-induced obesity mouse model at 15.2T. J Med Imaging (Bellingham) (2016) 0.75

Adding fat to the fire. Nat Med (2013) 0.75

A direct comparison of quality of life in obese and Cushing's syndrome patients. Eur J Endocrinol (2013) 0.75

Validation of the Italian version of the Laval questionnaire: health-related quality of life in subjects with obesity. Health Qual Life Outcomes (2017) 0.75

Comparison of brain serotonin transporter using [I-123]-ADAM between obese and non-obese young adults without an eating disorder. PLoS One (2017) 0.75

Obesity as a Socially Defined Disease: Philosophical Considerations and Implications for Policy and Care. Health Care Anal (2016) 0.75

Evaluation of the association between the TAS1R2 and TAS1R3 variants and food intake and nutritional status in children. Genet Mol Biol (2017) 0.75

A Mindfulness-Based Lifestyle Intervention for Obese, Inactive Endometrial Cancer Survivors: A Feasibility Study. Integr Cancer Ther (2016) 0.75

Food addiction and obesity: unnecessary medicalization of hedonic overeating. Nat Rev Endocrinol (2017) 0.75

Articles by these authors

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation (2009) 35.24

Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 16.52

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91

Obesity and metabolic syndrome in circadian Clock mutant mice. Science (2005) 12.66

Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med (2009) 12.38

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation (2002) 9.04

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation (2005) 8.59

Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52

DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med (2006) 7.90

Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care (2006) 7.09

Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation (2005) 7.04

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93

Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation (2010) 6.86

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet (2006) 6.50

Interindividual variation in posture allocation: possible role in human obesity. Science (2005) 6.26

Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res (2004) 5.74

The metabolic syndrome. Endocr Rev (2008) 5.33

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol (2013) 5.24

Fast-food consumption among US adults and children: dietary and nutrient intake profile. J Am Diet Assoc (2003) 5.13

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract (2011) 4.69

Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation (2004) 4.29

Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med (2011) 4.28

Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res (2002) 4.09

Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial. Arch Intern Med (2012) 3.95

Splanchnic lipolysis in human obesity. J Clin Invest (2004) 3.94

A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes (2005) 3.84

A guide to analysis of mouse energy metabolism. Nat Methods (2011) 3.82

2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63

Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation (2009) 3.59

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA (2013) 3.49

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr (2009) 3.39

Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA (2003) 3.36

2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 3.35

Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34

Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab (2009) 3.29

Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study. Obesity (Silver Spring) (2007) 3.23

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation (2010) 3.16

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol (2006) 3.11

Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab (2006) 3.03

Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev (2006) 2.99

Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med (2012) 2.90

Sex, race/ethnicity, socioeconomic status, and BMI in relation to self-perception of overweight. Obes Res (2002) 2.87

Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med (2006) 2.86

Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes (2005) 2.76

Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71

Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes (2003) 2.53

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes (2003) 2.51

Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain. Proc Natl Acad Sci U S A (2013) 2.50

Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care (2003) 2.49

Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association. Circulation (2009) 2.49

The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring) (2010) 2.47

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol (2006) 2.41

Environment, obesity, and cardiovascular disease risk in low-income women. Am J Prev Med (2006) 2.39

Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38

Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1. J Clin Invest (2002) 2.38

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol (2005) 2.31

Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31

The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. Sleep (2008) 2.30

The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab (2008) 2.27

Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am J Roentgenol (2004) 2.26

The DASH diet for high blood pressure: from clinical trial to dinner table. Cleve Clin J Med (2004) 2.23

Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol (2002) 2.23

Cost effectiveness of internet interventions: review and recommendations. Ann Behav Med (2009) 2.21

The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ (2006) 2.20

State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation (2008) 2.17

Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A (2010) 2.17

Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation (2002) 2.17

Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. Arch Intern Med (2010) 2.17

Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab (2004) 2.16

Medical costs and productivity losses due to interpersonal and self-directed violence in the United States. Am J Prev Med (2007) 2.15

Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing endothelial nitric oxide synthase in healthy normolipidemic older adults. Hypertension (2012) 2.13

Cancer treatment cost in the United States: has the burden shifted over time? Cancer (2010) 2.10

Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. J Clin Invest (2005) 2.10

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin (2010) 2.05

Effect of a stepped-care intervention approach on weight loss in adults: a randomized clinical trial. JAMA (2012) 2.02

The doctor is in charge: how the ACA puts the employee's physician in charge of the wellness program. J Policy Anal Manage (2014) 1.97

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. JAMA (2003) 1.97

Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr (2012) 1.96

Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care (2005) 1.96

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther (2008) 1.95

How bad is fructose? Am J Clin Nutr (2007) 1.93

Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res (2003) 1.92

Video game playing increases food intake in adolescents: a randomized crossover study. Am J Clin Nutr (2011) 1.92

WNT5A mutations in patients with autosomal dominant Robinow syndrome. Dev Dyn (2010) 1.91

Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes (2007) 1.88

Public perceptions of childhood obesity. Am J Prev Med (2005) 1.85

Energy expenditure during sleep, sleep deprivation and sleep following sleep deprivation in adult humans. J Physiol (2010) 1.81

Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. J Lipid Res (2008) 1.80

Subcutaneous adipocyte size and body fat distribution. Am J Clin Nutr (2008) 1.80